BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30387554)

  • 1. Novel flavagline-like compounds with potent Fli-1 inhibitory activity suppress diverse types of leukemia.
    Song J; Yuan C; Yang J; Liu T; Yao Y; Xiao X; Gajendran B; Xu D; Li YJ; Wang C; Liu W; Wen M; Spaner D; Filmus J; Zacksenhaus E; Zhang Y; Hao X; Ben-David Y
    FEBS J; 2018 Dec; 285(24):4631-4645. PubMed ID: 30387554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of diterpenoid compounds that interfere with Fli-1 DNA binding to suppress leukemogenesis.
    Liu T; Xia L; Yao Y; Yan C; Fan Y; Gajendran B; Yang J; Li YJ; Chen J; Filmus J; Spaner DE; Zacksenhaus E; Hao X; Ben-David Y
    Cell Death Dis; 2019 Feb; 10(2):117. PubMed ID: 30741932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A screen for Fli-1 transcriptional modulators identifies PKC agonists that induce erythroid to megakaryocytic differentiation and suppress leukemogenesis.
    Liu T; Yao Y; Zhang G; Wang Y; Deng B; Song J; Li X; Han F; Xiao X; Yang J; Xia L; Li YJ; Plachynta M; Zhang M; Yan C; Mu S; Luo H; Zacksenhaus E; Hao X; Ben-David Y
    Oncotarget; 2017 Mar; 8(10):16728-16743. PubMed ID: 28052010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FLI1 promotes protein translation via the transcriptional regulation of MKNK1 expression.
    Wang C; Song J; Liu W; Yao Y; Kapranov P; Sample KM; Gajendran B; Zacksenhaus E; Hao X; Ben-David Y
    Int J Oncol; 2020 Feb; 56(2):430-438. PubMed ID: 31894299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1.
    Ben-David Y; Giddens EB; Letwin K; Bernstein A
    Genes Dev; 1991 Jun; 5(6):908-18. PubMed ID: 2044959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fli-1 promotes proliferation and upregulates NANOGP8 expression in T-lymphocyte leukemia cells.
    Park SW; Do HJ; Choi W; Kim JH
    Biochimie; 2020 Jan; 168():1-9. PubMed ID: 31626853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective ERK1/2 agonists isolated from Melia azedarach with potent anti-leukemic activity.
    Wang N; Fan Y; Yuan CM; Song J; Yao Y; Liu W; Gajendran B; Zacksenhaus E; Li Y; Liu J; Hao XJ; Ben-David Y
    BMC Cancer; 2019 Aug; 19(1):764. PubMed ID: 31375085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribavirin Inhibits the Activity of mTOR/eIF4E, ERK/Mnk1/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph+ Leukemia.
    Shi F; Len Y; Gong Y; Shi R; Yang X; Naren D; Yan T
    PLoS One; 2015; 10(8):e0136746. PubMed ID: 26317515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias.
    Yi H; Fujimura Y; Ouchida M; Prasad DD; Rao VN; Reddy ES
    Oncogene; 1997 Mar; 14(11):1259-68. PubMed ID: 9178886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The GATA-1 and Spi-1 transcriptional factors bind to a GATA/EBS dual element in the Fli-1 exon 1.
    Barbeau B; Barat C; Bergeron D; Rassart E
    Oncogene; 1999 Sep; 18(40):5535-45. PubMed ID: 10523830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective anticancer effects of a synthetic flavagline on human Oct4-expressing cancer stem-like cells via a p38 MAPK-dependent caspase-3-dependent pathway.
    Emhemmed F; Ali Azouaou S; Thuaud F; Schini-Kerth V; Désaubry L; Muller CD; Fuhrmann G
    Biochem Pharmacol; 2014 May; 89(2):185-96. PubMed ID: 24607276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marsdenia tenacissimae extraction (MTE) inhibits the proliferation and induces the apoptosis of human acute T cell leukemia cells through inactivating PI3K/AKT/mTOR signaling pathway via PTEN enhancement.
    Wang Y; Chen B; Wang Z; Zhang W; Hao K; Chen Y; Li K; Wang T; Xie Y; Huang Z; Tong X
    Oncotarget; 2016 Dec; 7(50):82851-82863. PubMed ID: 27756877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous Fli-1 expression plays an essential role in the proliferation and survival of F-MuLV-induced erythroleukemia and human erythroleukemia.
    Cui JW; Vecchiarelli-Federico LM; Li YJ; Wang GJ; Ben-David Y
    Leukemia; 2009 Jul; 23(7):1311-9. PubMed ID: 19282832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma.
    Loganathan SN; Tang N; Fleming JT; Ma Y; Guo Y; Borinstein SC; Chiang C; Wang J
    Oncotarget; 2016 Jul; 7(28):43504-43517. PubMed ID: 27259270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fli-1b is generated by usage of differential splicing and alternative promoter.
    Dhulipala PD; Lee L; Rao VN; Reddy ES
    Oncogene; 1998 Sep; 17(9):1149-57. PubMed ID: 9764825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FLI-1 inhibits differentiation and induces proliferation of primary erythroblasts.
    Pereira R; Quang CT; Lesault I; Dolznig H; Beug H; Ghysdael J
    Oncogene; 1999 Feb; 18(8):1597-608. PubMed ID: 10102630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms and anti-cancer aspects of the medicinal phytochemicals rocaglamides (=flavaglines).
    Li-Weber M
    Int J Cancer; 2015 Oct; 137(8):1791-9. PubMed ID: 24895251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-mediated inhibition of Fli-1 for the treatment of leukemia.
    Li YJ; Zhao X; Vecchiarelli-Federico LM; Li Y; Datti A; Cheng Y; Ben-David Y
    Blood Cancer J; 2012 Jan; 2(1):e54. PubMed ID: 22829238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Fli-1 in normal cell function and malignant transformation.
    Truong AH; Ben-David Y
    Oncogene; 2000 Dec; 19(55):6482-9. PubMed ID: 11175364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nemorosone blocks proliferation and induces apoptosis in leukemia cells.
    Díaz-Carballo D; Malak S; Freistühler M; Elmaagacli A; Bardenheuer W; Reusch HP
    Int J Clin Pharmacol Ther; 2008 Aug; 46(8):428-39. PubMed ID: 18793585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.